CNN Research Feature: Metformin & Pregnancy Risk
New research featured in CNN challenges past scholarship on metformin and its impact on pregnancy.
The study by Yu-Han Chiu et al published in Annals of Internal Medicine found that women with diabetes type 2 who continued using metformin as a treatment in their first trimester of pregnancy showed no increased risk for giving birth to a baby with major birth defects when compared with women who discontinued metformin.
Dr. Yu-Han Chiu, the lead author of the study, is a CAUSALab researcher collaborator and current faculty member at Penn State College of Medicine. This work was supported and advised by CAUSALab Director Miguel Hernán and Sonia Hernández-Díaz, Professor of Epidemiology and Co-Director of Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (H4P) at Harvard T.H. Chan School of Public Health.
Read the full CNN article.
Read the original publications in Annals of Internal Medicine.
